พิมิดา 500 มก.
PEMEDA 500 MG
activeLast updated: 2026-07-29
Product & certifications 1
- FDA 1C32/67(NG)drugคงอยู่
ตัวยาสำคัญ
- PEMETREXED DISODIUM500 milligramต่อ 1 vial
- ประเภทควบคุม
- ยาควบคุมพิเศษ
- ข้อบ่งใช้
- Therapeutic indication 1. Nonsquamous Non-Small Cell Lung Cancer - Combination with Cisplatin Pemetrexed for Injection is indicated in combination with cisplatin therapy for the initial treatment of patients with locally advanced or metastatic nonsquamous non-small cell lung cancer. 2. Nonsquamous Non-Small Cell Lung Cancer - Maintenance Pemetrexed for Injection is indicated for the maintenance treatment of patients with locally advanced or metastatic nonsquamous non-small cell lung cancer whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. 3. Nonsquamous Non-Small Cell Lung Cancer - After Prior Chemotherapy Pemetrexed for Injection is indicated as a single-agent for the treatment of patients with locally advanced or metastatic nonsquamous non-small cell lung cancer after prior chemotherapy. 4. Mesothelioma Pemetrexed for Injection in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery.
- รหัส ATC
- L01BA04 (pemetrexed)
ข้อมูลตามที่ขึ้นทะเบียนกับ อย. — ไม่ใช่คำแนะนำการใช้ยา ปรึกษาเภสัชกรหรือแพทย์ก่อนใช้เสมอ
- Category
- ยาสำเร็จรูป
- Trade name
- —
- Company / Manufacturer
- บริษัท อิคารอส ฟาร์มาซูติคัล จำกัดดำเนินกิจการ
- Juristic registration number
- 0105564057278
- Producer's other permits
- See all permits held by this company →
A matching registration number confirms the registration exists — it does not verify that the physical item you hold is genuine. Always compare the product and manufacturer names on the label.
Last updated: 2026-07-29 · Data aggregated from official government databases: NBTC · FDA · TISI · DBD · Dept. of Tourism · ACFSReport incorrect data